Overview of the global pharmaceutical market

Drug development begins with the synthesis of the drug, then the drug undergoes preclinical trials (on animals), clinical trials (on humans, phases I - III), and only after that it goes on sale. The largest number of drugs are created for the treatment of cancer, infectious diseases, diseases of the central nervous system. (see table)

Statistics of drug trials by stages of trials/ clinical trials (CI)Diagrams to the table

Drugs undergoing testing (by test stages)

A total of 28,844 drugs

Drugs undergoing trials (by therapeutic areas)

A total of 28,858 drugsRecently put on the market

A total of 4,337 drugs

The entire process of bringing the drug to the market takes 6-12 years, and the cost of developing the drug is 600-1200 million US dollars.

At the same time, out of 100,000 substances studied, only 100 pass clinical trials, only 10 of them go on sale and only 2 make a profit. Nevertheless, the revenues of pharmaceutical companies are increasing every year.

Therapeutic drugs market forecastBioPharm Insight, 11.05.2007

The income of companies with commercial drugs in their portfolio is growing every year.

Biotech companies with commercial drugs in their portfolio